The Effect of Cosmetic Face Care Products on Facial Skin Tone and Spot Brightening

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

250 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-22

Study Completion Date

2025-11-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a single centre, 5-cell, blinded study to evaluate changes in even skin tone, skin glow, facial pigmented spots, and the microbiome of facial skin following the use of cosmetic face care products on the whole face over a 12 week period.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Cosmetic Products on Skin Brightening

NCT06899321

Skin Brightening

NOT_YET_RECRUITING NA

Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma

NCT06278948

Melasma

RECRUITING NA

Process Validation in Dermatology: Assessing Methods for UV Exposure (Artificial Source vs. Sunlight) and Efficacy Evaluation of Anti-Tanning Agents

NCT06384092

Skin Pigmentation

COMPLETED NA

Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE, Under Real Sun Exposure

NCT04865055

Real Life Pigmentation

UNKNOWN NA

Evaluation of the Photoprotection Efficacy with Sunscreen Formulas Under Visible Light Exposure

NCT06803901

Efficacy of Sunscreen Products Healthy Back Skin Pigmentation Induced by Visible Light Exposure

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a randomized, blinded, 5 cell, full-face study designed to evaluate changes in even skin tone, skin glow, pigmented spots and the surface microbiome of facial skin following the use of one of five cosmetic face care products. This study will accept up to 50 participants per cell (250 participants overall) who meet the inclusion/exclusion criteria to ensure that at least 40 participants per cell complete the study. Participants will be randomised to receive one of the five cosmetic face care products which will be applied to the whole face using a defined protocol.

If accepted onto the study, all participants will be provided with a marketed face wash to use for one week prior to the baseline visit and throughout the whole study.

Visual and instrumental assessments of skin colour, skin glow and even tone will be conducted throughout the duration of the study (12 weeks product use and 6 weeks regression). Non-invasive skin surface samples will be collected at several timepoints for evaluation of the skin microbiome.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pigment Spots

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Statistician

Intervention Type OTHER

Cosmetic face care product

Cosmetic face care product

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female adult participants in general good health as determined from a recent medical history.
* Participants in the age group of 20-45 years (both ages inclusive).
* Participants having Fitzpatrick photo-type III-V.
* Participants with at least 3 spots on the cheek either of PIH post acne/age related
* Participants not presenting any skin condition that may interfere with the assessment for the entire study duration.
* Participants free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face
* Participant who agrees not to use any other product/treatment/home remedy/serum on their face during the study period other than the study product.
* Participants who agree to remove all jewellery on/around face (e.g., necklace, earrings, nose ring), during imaging.
* Participants willing to give a voluntary written informed consent and photography release.
* Participants willing to abide by and comply with the study protocol.
* Participants able to read, understand and sign an appropriate informed consent form indicating her willingness to participate.
* Participants willing and capable to follow the study rules and a fixed schedule.

Exclusion Criteria

* Participants who are currently participating in a similar study or have participated in a similar study in the past 6 weeks.
* Participants with any other signs of significant local irritation, erythema, or skin disease on skin.
* Participants having chronic illness or who have undergone major surgery in the last year that may be clinically relevant or can impact the results as determined by the dermatologist.
* Participants undergoing treatment for any skin condition.
* Participants allergic or sensitive to bar cleansing products, creams/lotions, artificial jewellery or anything else.
* Participants with self-perceived pimple prone and/or sensitive skin.
* Participants taking any oral antibiotic medication currently or within the last 8 weeks.
* Participants taking medication continuously/regularly every day such as corticosteroids or non-steroidal anti-inflammatories, topically for four weeks or orally for eight weeks prior to the study.
* Female participant pregnant/breast feeding or planning pregnancy during the study period (self-declared)
* Participants taking product/treatment for any condition which the Investigator believes may influence the interpretation of the data.
* Participants currently taking any medication, which the investigator believes may influence the interpretation of the data.

Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes